Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:00:08 EST Sat 21 Nov 2026
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR+ Search
SEDAR+ Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR+ Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:CYTK
- CYTOKINETICS INC -
https://www.cytokinetics.com
18:00:08 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
CYTK
- Q
0.1
45.58
·
53.70
0.1
50.78
-0.68
-1.3
1,426.7
72,413
14,310
51.27
53.45
50.60
88.31 50.32
19:38:39
Nov 16
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Portfolio
Recent Trades - Last 10 of 14310
More trades...
Time ET
Ex
Price
Change
Volume
19:38:39
Q
52.4809
1.0209
3,000
19:36:06
Q
51.50
0.04
4
19:30:06
Q
50.609
-0.851
1
19:30:06
Q
50.609
-0.851
1
19:30:06
Q
50.609
-0.851
1
19:30:05
Q
50.609
-0.851
1
19:30:05
Q
50.609
-0.851
1
18:29:59
Q
50.60
-0.86
40
17:56:54
Q
51.20
-0.26
1
17:47:38
Q
50.69
-0.77
10
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2026-11-16 16:00
U:CYTK
News Release
200
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-16 04:00
U:CYTK
News Release
200
Cytokinetics Announces Prescribing Information for MYQORZO(TM) (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM
2026-11-09 07:30
U:CYTK
News Release
200
Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
2026-11-04 16:00
U:CYTK
News Release
200
Cytokinetics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-03 16:00
U:CYTK
News Release
200
Cytokinetics to Participate in November Investor Conferences
2026-11-02 07:30
U:CYTK
News Release
200
Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
2026-10-21 16:00
U:CYTK
News Release
200
Cytokinetics to Announce Third Quarter Results on November 4, 2026
2026-10-19 16:00
U:CYTK
News Release
200
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-19 07:30
U:CYTK
News Release
200
Cytokinetics Announces Health Canada Approval of MYQORZO(TM) (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
2026-10-12 16:00
U:CYTK
News Release
200
Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026
2026-10-02 07:30
U:CYTK
News Release
200
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
2026-09-30 07:30
U:CYTK
News Release
200
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO(TM) (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
2026-09-17 16:00
U:CYTK
News Release
200
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-14 07:30
U:CYTK
News Release
200
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
2026-09-02 16:00
U:CYTK
News Release
200
Cytokinetics to Participate in September Investor Conferences
2026-08-29 10:30
U:CYTK
News Release
200
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
2026-08-28 05:45
U:CYTK
News Release
200
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
2026-08-20 07:30
U:CYTK
News Release
200
Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
2026-08-18 16:00
U:CYTK
News Release
200
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06 16:00
U:CYTK
News Release
200
Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update